rivastigmine

Known as: Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate, M-((S)-1-(Dimethylamino)ethyl)phenyl Ethylmethylcarbamate 
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Delirium is frequently diagnosed in critically ill patients and is associated with adverse outcome. Impaired… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To assess the effect of rivastigmine in patients with mild cognitive impairment (MCI) on the time to clinical diagnosis… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES Randomised controlled trials that directly compare cholinesterase inhibitors for the treatment of Alzheimer's disease… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Rivastigmine, a carbamate inhibitor of acetylcholinesterase, is already in use for treatment of Alzheimer's disease under the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
This study was designed to assess the effects of rivastigmine (Exelon) on the cognitive functioning of patients suffering from… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Dementia with Lewy bodies is a common form of dementia in the elderly, characterised clinically by fluctuating… (More)
Is this relevant?